Skip to main content
Erschienen in: Intensive Care Medicine 2/2020

13.02.2020 | Narrative Review

Treatment of Ebola-related critical illness

verfasst von: Peter Kiiza, S. Mullin, K. Teo, N. K. J. Adhikari, R. A. Fowler

Erschienen in: Intensive Care Medicine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore contemporary clincial case management of patients with Ebola virus disease.

Methods

A narrative review from a clinical perspective of clinical features, diagnostic tests, treatments and outcomes of patients with Ebola virus disease.

Results

Substantial advances have been made in the care of patients with Ebola virus disease (EVD), precipitated by the unprecedented extent of the 2014–2016 outbreak. There has been improved point-of-care diagnostics, improved characterization of the clinical course of EVD, improved patient-optimized standards of care, evaluation of effective anti-Ebola therapies, administration of effective vaccines, and development of innovative Ebola treatment units. A better understanding of the Ebola virus disease clinical syndrome has led to the appreciation of a central role for critical care clinicians—over 50% of patients have life-threatening complications, including hypotension, severe electrolyte imbalance, acute kidney injury, metabolic acidosis and respiratory failure. Accordingly, patients often require critical care interventions such as monitoring of vital signs, intravenous fluid resuscitation, intravenous vasoactive medications, frequent diagnostic laboratory testing, renal replacement therapy, oxygen and occasionally mechanical ventilation.

Conclusion

With advanced training and adherence to infection prevention and control practices, clinical interventions, including critical care, are feasible and safe to perform in critically ill patients. With specific anti-Ebola medications, most patients can survive Ebola virus infection.
Literatur
1.
Zurück zum Zitat Fowler RA, Fletcher T, Fischer WA, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O’Dempsey T, Ferri M (2014) Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190(7):733–737PubMedCrossRef Fowler RA, Fletcher T, Fischer WA, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O’Dempsey T, Ferri M (2014) Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190(7):733–737PubMedCrossRef
2.
Zurück zum Zitat Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A (2016) Ebola virus disease and critical illness. Crit Care 20(1):217PubMedPubMedCentralCrossRef Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A (2016) Ebola virus disease and critical illness. Crit Care 20(1):217PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA, Fowler RA (2014) Doing today's work superbly well—treating Ebola with current tools. N Engl J Med 371(17):1565–1566PubMedCrossRef Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA, Fowler RA (2014) Doing today's work superbly well—treating Ebola with current tools. N Engl J Med 371(17):1565–1566PubMedCrossRef
4.
Zurück zum Zitat Malvy D, McElroy AK, de Clerck H, Günther S, van Griensven J (2019) Ebola virus disease. Lancet 393(10174):936–948PubMedCrossRef Malvy D, McElroy AK, de Clerck H, Günther S, van Griensven J (2019) Ebola virus disease. Lancet 393(10174):936–948PubMedCrossRef
5.
Zurück zum Zitat Lamontagne F, Clément C, Kojan R, Godin M, Kabuni P, Fowler RA (2019) The evolution of supportive care for Ebola virus disease. Lancet 393(10172):620–621PubMedCrossRef Lamontagne F, Clément C, Kojan R, Godin M, Kabuni P, Fowler RA (2019) The evolution of supportive care for Ebola virus disease. Lancet 393(10172):620–621PubMedCrossRef
6.
Zurück zum Zitat Rojek A, Horby P, Dunning J (2017) Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis 17(9):e280–e292PubMedPubMedCentralCrossRef Rojek A, Horby P, Dunning J (2017) Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis 17(9):e280–e292PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, Heisenberg-Mansaray S, Tamba E, Sheriff A, Conteh S, Smith T (2015) Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 15(11):1292–1299PubMedCrossRef Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, Heisenberg-Mansaray S, Tamba E, Sheriff A, Conteh S, Smith T (2015) Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 15(11):1292–1299PubMedCrossRef
9.
Zurück zum Zitat Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA 2nd, Fletcher TE (2018) Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 391(10121):700–708PubMedCrossRef Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA 2nd, Fletcher TE (2018) Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 391(10121):700–708PubMedCrossRef
10.
Zurück zum Zitat Clément C, Adhikari NK, Lamontagne F (2019) Evidence-based clinical management of Ebola virus disease and epidemic viral hemorrhagic fevers. Infect Dis Clin 33(1):247–264CrossRef Clément C, Adhikari NK, Lamontagne F (2019) Evidence-based clinical management of Ebola virus disease and epidemic viral hemorrhagic fevers. Infect Dis Clin 33(1):247–264CrossRef
12.
Zurück zum Zitat Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L (2016) Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 374(7):636–646PubMedPubMedCentralCrossRef Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L (2016) Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 374(7):636–646PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Dickson SJ, Clay KA, Adam M, Ardley C, Bailey MS, Burns DS, Cox AT, Craig DG, Espina M, Ewington I, Fitchett G (2018) Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone. J Infect 76(4):383–392PubMedPubMedCentralCrossRef Dickson SJ, Clay KA, Adam M, Ardley C, Bailey MS, Burns DS, Cox AT, Craig DG, Espina M, Ewington I, Fitchett G (2018) Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone. J Infect 76(4):383–392PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA (2019) The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018–2019. N Engl J Med 381:373–383PubMedCrossRef Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA (2019) The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018–2019. N Engl J Med 381:373–383PubMedCrossRef
20.
Zurück zum Zitat Kuhn JH, Adachi T, Adhikari NK, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH (2019) New filovirus disease classification and nomenclature. Nat Rev Microbiol 5:261CrossRef Kuhn JH, Adachi T, Adhikari NK, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH (2019) New filovirus disease classification and nomenclature. Nat Rev Microbiol 5:261CrossRef
22.
23.
Zurück zum Zitat Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM (2017) The pathogenesis of Ebola virus disease. Annu Rev Pathol 12:387–418PubMedCrossRef Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM (2017) The pathogenesis of Ebola virus disease. Annu Rev Pathol 12:387–418PubMedCrossRef
24.
Zurück zum Zitat Diallo B, Sissoko D, Loman NJ, Bah HA, Bah H, Worrell MC, Conde LS, Sacko R, Mesfin S, Loua A, Kalonda JK (2016) Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63(10):1353–1356PubMedPubMedCentralCrossRef Diallo B, Sissoko D, Loman NJ, Bah HA, Bah H, Worrell MC, Conde LS, Sacko R, Mesfin S, Loua A, Kalonda JK (2016) Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63(10):1353–1356PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Munoz-Fontela C, McElroy AK (2017) Ebola virus disease in humans: pathophysiology and immunity. Curr Top Microbiol Immunol 411:141–169PubMedPubMedCentral Munoz-Fontela C, McElroy AK (2017) Ebola virus disease in humans: pathophysiology and immunity. Curr Top Microbiol Immunol 411:141–169PubMedPubMedCentral
27.
Zurück zum Zitat Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ (1996) Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70(4):2208–2214PubMedPubMedCentralCrossRef Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ (1996) Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70(4):2208–2214PubMedPubMedCentralCrossRef
29.
30.
Zurück zum Zitat Rojek AM, Salam A, Ragotte RJ, Liddiard E, Elhussain A, Carlqvist A, Butler M, Kayem N, Castle L, Lang’o O, Stepniewska K (2019) A systematic review and meta-analysis of patient data from the west Africa (2013–16) Ebola virus disease epidemic. Clin Microbiol Infect 25(11):1307–1314PubMedPubMedCentralCrossRef Rojek AM, Salam A, Ragotte RJ, Liddiard E, Elhussain A, Carlqvist A, Butler M, Kayem N, Castle L, Lang’o O, Stepniewska K (2019) A systematic review and meta-analysis of patient data from the west Africa (2013–16) Ebola virus disease epidemic. Clin Microbiol Infect 25(11):1307–1314PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Lado M, Walker NF, Baker P, Haroon S, Brown CS, Youkee D, Studd N, Kessete Q, Maini R, Boyles T, Hanciles E (2015) Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis 15(9):1024–1033PubMedCrossRef Lado M, Walker NF, Baker P, Haroon S, Brown CS, Youkee D, Studd N, Kessete Q, Maini R, Boyles T, Hanciles E (2015) Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis 15(9):1024–1033PubMedCrossRef
32.
Zurück zum Zitat Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A (2014) Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med 371(22):2054–2057PubMedCrossRef Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A (2014) Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med 371(22):2054–2057PubMedCrossRef
35.
Zurück zum Zitat Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G (2019) Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn 19(4):325–340PubMedCrossRef Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G (2019) Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn 19(4):325–340PubMedCrossRef
37.
Zurück zum Zitat Gallais F, Gay-Andrieu F, Picot V, Magassouba N, Mély S, Peyrefitte CN, Bellanger L (2017) Field assessment of the new rapid diagnostic test Ebola eZYSCREEN®. Bull Soc Pathol Exot (1990) 110(1):38–48CrossRef Gallais F, Gay-Andrieu F, Picot V, Magassouba N, Mély S, Peyrefitte CN, Bellanger L (2017) Field assessment of the new rapid diagnostic test Ebola eZYSCREEN®. Bull Soc Pathol Exot (1990) 110(1):38–48CrossRef
38.
Zurück zum Zitat Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB (2015) Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Eurosurveillance 20(12):21073PubMedCrossRef Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB (2015) Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Eurosurveillance 20(12):21073PubMedCrossRef
39.
Zurück zum Zitat Engwa GA (2018) Ebola virus disease: progress so far in the management of the disease. Curr Top Trop Emerg Dis Travel Med 19:129 Engwa GA (2018) Ebola virus disease: progress so far in the management of the disease. Curr Top Trop Emerg Dis Travel Med 19:129
40.
Zurück zum Zitat Makiala S, Mukadi D, De Weggheleire A, Muramatsu S, Kato D, Inano K, Gondaira F, Kajihara M, Yoshida R, Changula K, Mweene A (2019) Clinical evaluation of QuickNaviTM-Ebola in the 2018 outbreak of Ebola virus disease in the Democratic Republic of the Congo. Viruses 11(7):589PubMedCentralCrossRef Makiala S, Mukadi D, De Weggheleire A, Muramatsu S, Kato D, Inano K, Gondaira F, Kajihara M, Yoshida R, Changula K, Mweene A (2019) Clinical evaluation of QuickNaviTM-Ebola in the 2018 outbreak of Ebola virus disease in the Democratic Republic of the Congo. Viruses 11(7):589PubMedCentralCrossRef
41.
Zurück zum Zitat Kiiza P, Adhikari NK, Mullin S, Teo K, Fowler RA (2019) Principles and practices of establishing a hospital-based Ebola treatment unit. Crit Care Clin 35(4):697–710PubMedCrossRef Kiiza P, Adhikari NK, Mullin S, Teo K, Fowler RA (2019) Principles and practices of establishing a hospital-based Ebola treatment unit. Crit Care Clin 35(4):697–710PubMedCrossRef
42.
Zurück zum Zitat Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 389(10068):505–518PubMedPubMedCentralCrossRef Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 389(10068):505–518PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Damon IK, Rollin PE, Choi MJ, Arthur RR, Redfield RR (2018) New tools in the Ebola arsenal. N Engl J Med 379(21):1981–1983PubMedCrossRef Damon IK, Rollin PE, Choi MJ, Arthur RR, Redfield RR (2018) New tools in the Ebola arsenal. N Engl J Med 379(21):1981–1983PubMedCrossRef
45.
Zurück zum Zitat Prevail II Writing Group (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. New Engl J Med 375(15):1448–56CrossRef Prevail II Writing Group (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. New Engl J Med 375(15):1448–56CrossRef
46.
Zurück zum Zitat Ansumana R, Jacobsen KH, Idris MB, Bangura H, Boie-Jalloh M, Lamin JM, Sesay S, Sahr F (2015) Ebola in Freetown area, Sierra Leone—a case study of 581 patients. N Engl J Med 372(6):587–588PubMedCrossRef Ansumana R, Jacobsen KH, Idris MB, Bangura H, Boie-Jalloh M, Lamin JM, Sesay S, Sahr F (2015) Ebola in Freetown area, Sierra Leone—a case study of 581 patients. N Engl J Med 372(6):587–588PubMedCrossRef
47.
Zurück zum Zitat Connor MJ, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA (2015) Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol 26(1):31–37PubMedCrossRef Connor MJ, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA (2015) Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol 26(1):31–37PubMedCrossRef
48.
Zurück zum Zitat Lee JS, Adhikari NK, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J et al (2019) Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis 19(1):376PubMedPubMedCentralCrossRef Lee JS, Adhikari NK, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J et al (2019) Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis 19(1):376PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Sivapalasingam S, Kamal M, Slim R, Hosain R, Shao W, Stoltz R, Yen J, Pologe LG, Cao Y, Partridge M, Sumner G (2018) Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomized, first-in-human phase 1 study. Lancet Infect Dis 18(8):884–893PubMedCrossRef Sivapalasingam S, Kamal M, Slim R, Hosain R, Shao W, Stoltz R, Yen J, Pologe LG, Cao Y, Partridge M, Sumner G (2018) Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomized, first-in-human phase 1 study. Lancet Infect Dis 18(8):884–893PubMedCrossRef
51.
Zurück zum Zitat Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M (2019) Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet 393(10174):889–898PubMedPubMedCentralCrossRef Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M (2019) Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet 393(10174):889–898PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R (2019) A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 381(24):2293–2303PubMedCrossRef Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R (2019) A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 381(24):2293–2303PubMedCrossRef
53.
Zurück zum Zitat Warren T, Jordan R, Lo M, Soloveva V, Ray A, Bannister R, Mackman R, Perron M, Stray K, Feng J, Xu Y (2015) Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates. Infectious Diseases Society of America Open Forum Infectious Diseases 2(1) LB-2. https://academic.oup.com/ofid/article/2/suppl_1/LB-2/2633814. Accessed 17 Nov 2019 Warren T, Jordan R, Lo M, Soloveva V, Ray A, Bannister R, Mackman R, Perron M, Stray K, Feng J, Xu Y (2015) Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates. Infectious Diseases Society of America Open Forum Infectious Diseases 2(1) LB-2. https://​academic.​oup.​com/​ofid/​article/​2/​suppl_​1/​LB-2/​2633814. Accessed 17 Nov 2019
54.
Zurück zum Zitat Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A, Gifford RJ, Hopkins S, Hughes J, Jabeen F, Johannessen I (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388(10043):498–503PubMedPubMedCentralCrossRef Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A, Gifford RJ, Hopkins S, Hughes J, Jabeen F, Johannessen I (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388(10043):498–503PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Dörnemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M, Kolié MC, Yosifiva V, Caluwaerts S, McElroy AK, Antierens A (2017) First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis 215(2):171–174PubMedPubMedCentral Dörnemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M, Kolié MC, Yosifiva V, Caluwaerts S, McElroy AK, Antierens A (2017) First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis 215(2):171–174PubMedPubMedCentral
Metadaten
Titel
Treatment of Ebola-related critical illness
verfasst von
Peter Kiiza
S. Mullin
K. Teo
N. K. J. Adhikari
R. A. Fowler
Publikationsdatum
13.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 2/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-020-05949-z

Weitere Artikel der Ausgabe 2/2020

Intensive Care Medicine 2/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.